Abstract

BackgroundDepression is highly prevalent yet often poorly detected and treated among cancer patients. In light of the move towards evidence-based healthcare policy, we have developed a simple tool that can assist policy makers, organisations and researchers to logically think through the steps involved in improving patient outcomes, and to help guide decisions about where to allocate resources.MethodsThe model assumes that a series of filters operate to determine outcomes and cost-effectiveness associated with depression care for cancer patients, including: detection of depression, provider response to detection, patient acceptance of treatment, and effectiveness of treatment provided. To illustrate the utility of the model, hypothetical data for baseline and four scenarios in which filter outcomes were improved by 15% were entered into the model.ResultsThe model provides outcomes including: number of people successfully treated, total costs per scenario, and the incremental cost-effectiveness ratio per scenario compared to baseline. The hypothetical data entered into the model illustrate the relative effectiveness (in terms of the number of additional incremental successes) and relative cost-effectiveness (in terms of cost per successful outcome and total cost) of making changes at each step or filter.ConclusionsThe model provides a readily accessible tool to assist decision makers to think through the steps involved in improving depression outcomes for cancer patents. It provides transparent guidance about how to best allocate resources, and highlights areas where more reliable data are needed. The filter model presents an opportunity to improve on current practice by ensuring that a logical approach, which takes into account the available evidence, is applied to decision making.

Highlights

  • Depression is highly prevalent yet often poorly detected and treated among cancer patients

  • How can the treatment of depression among cancer patients be improved? Depression is a significant problem for cancer patients

  • A simple “filter model” to guide decisions about the investment of resources to improve the treatment of depression among cancer patients In light of the constraints mentioned above, we have developed a simple ‘filter model’ to assist decision and policy makers think through some of the key steps that influence patient outcomes in depression care in cancer

Read more

Summary

Introduction

Depression is highly prevalent yet often poorly detected and treated among cancer patients. In light of the move towards evidence-based healthcare policy, we have developed a simple tool that can assist policy makers, organisations and researchers to logically think through the steps involved in improving patient outcomes, and to help guide decisions about where to allocate resources. How can the treatment of depression among cancer patients be improved? Depression is a significant problem for cancer patients. The rate of occurrence of major depression among cancer patients is approximately two to four times that of the general population [1]. If depression outcomes for cancer patients are to be improved, the range of relevant steps and influences on outcomes need to be adequately considered. How should decisions about allocating resources to improve patient outcomes be made? Policymakers tend to rely on other types of evidence, such as personal experience, or the opinions of eminent colleagues, rather than research findings [14]

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.